John R Blosnich1, Keren Lehavot2,3,4, Joseph E Glass5, Emily C Williams2,4. 1. Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania. 2. Denver-Seattle Center of Innovation for Veteran-Centered Value-Driven Care, Veterans Affairs Puget Sound Health Services Research & Development, Seattle, Washington. 3. Department of Psychiatry and Behavioral Science, University of Washington, Seattle, Washington. 4. Department of Health Services, University of Washington, Seattle, Washington. 5. Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
Abstract
OBJECTIVE: Little is known regarding patterns of alcohol use and alcohol-related care among transgender adults. This study examined alcohol use and alcohol-related care across transgender status in a probability sample of U.S. adults. METHOD: We conducted secondary analyses of the 2014 Behavioral Risk Factor Surveillance System survey, focusing on adults in eight states that administered both an Alcohol Screening and Brief Intervention module and a Gender Identity module (n = 58,381). Measurements included transgender status, sociodemographic characteristics, alcohol consumption (any alcohol use, risky drinking, heavy episodic drinking, and any unhealthy alcohol use), and alcohol-related care (alcohol screening during healthcare visits and advice about unhealthy alcohol use). We tested the association between transgender status and alcohol consumption and alcohol-related care using multivariable logistic regression models adjusted for sociodemographic characteristics. RESULTS: Approximately 0.6% of respondents (n = 283) self-identified as transgender. Overall, there were no significant differences in alcohol consumption or screening between transgender and nontransgender adults. A greater proportion of transgender than nontransgender adults reported being advised to reduce alcohol use (20.7% vs. 7.8%, p = .012). However, this difference was not significant after adjusting for other sociodemographic characteristics (adjusted odds ratio = 2.31, 95% CI [0.91, 5.86], p = .077). CONCLUSIONS: In this representative sample from eight U.S. states, we did not find differences related to transgender status in rates of alcohol use or of alcohol-related care.
OBJECTIVE: Little is known regarding patterns of alcohol use and alcohol-related care among transgender adults. This study examined alcohol use and alcohol-related care across transgender status in a probability sample of U.S. adults. METHOD: We conducted secondary analyses of the 2014 Behavioral Risk Factor Surveillance System survey, focusing on adults in eight states that administered both an Alcohol Screening and Brief Intervention module and a Gender Identity module (n = 58,381). Measurements included transgender status, sociodemographic characteristics, alcohol consumption (any alcohol use, risky drinking, heavy episodic drinking, and any unhealthy alcohol use), and alcohol-related care (alcohol screening during healthcare visits and advice about unhealthy alcohol use). We tested the association between transgender status and alcohol consumption and alcohol-related care using multivariable logistic regression models adjusted for sociodemographic characteristics. RESULTS: Approximately 0.6% of respondents (n = 283) self-identified as transgender. Overall, there were no significant differences in alcohol consumption or screening between transgender and nontransgender adults. A greater proportion of transgender than nontransgender adults reported being advised to reduce alcohol use (20.7% vs. 7.8%, p = .012). However, this difference was not significant after adjusting for other sociodemographic characteristics (adjusted odds ratio = 2.31, 95% CI [0.91, 5.86], p = .077). CONCLUSIONS: In this representative sample from eight U.S. states, we did not find differences related to transgender status in rates of alcohol use or of alcohol-related care.
Authors: Rita M Melendez; Theresa A Exner; Anke A Ehrhardt; Brian Dodge; Robert H Remien; Mary-Jane Rotheram-Borus; Marguerita Lightfoot; Daniel Hong Journal: Am J Public Health Date: 2005-08-30 Impact factor: 9.308
Authors: John R Blosnich; George R Brown; Jillian C Shipherd Phd; Michael Kauth; Rebecca I Piegari; Robert M Bossarte Journal: Am J Public Health Date: 2013-08-15 Impact factor: 9.308
Authors: Daniel E Jonas; James C Garbutt; Halle R Amick; Janice M Brown; Kimberly A Brownley; Carol L Council; Anthony J Viera; Tania M Wilkins; Cody J Schwartz; Emily M Richmond; John Yeatts; Tammeka Swinson Evans; Sally D Wood; Russell P Harris Journal: Ann Intern Med Date: 2012-11-06 Impact factor: 25.391
Authors: Robert W S Coulter; John R Blosnich; Leigh A Bukowski; A L Herrick; Daniel E Siconolfi; Ron D Stall Journal: Drug Alcohol Depend Date: 2015-07-16 Impact factor: 4.492
Authors: E F S Kaner; F Beyer; H O Dickinson; E Pienaar; F Campbell; C Schlesinger; N Heather; J Saunders; B Burnand Journal: Cochrane Database Syst Rev Date: 2007-04-18
Authors: Jeffrey S Becasen; Christa L Denard; Mary M Mullins; Darrel H Higa; Theresa Ann Sipe Journal: Am J Public Health Date: 2018-11-29 Impact factor: 9.308
Authors: Ethan C Cicero; Sari L Reisner; Elizabeth I Merwin; Janice C Humphreys; Susan G Silva Journal: Nurs Res Date: 2020 Jul/Aug Impact factor: 2.381
Authors: Nodira Codell; A Taylor Kelley; Audrey L Jones; Matthew T Dungan; Natalie Valentino; Ana I Holtey; Tania J Knight; Amy Butz; Christina Gallop; Sean Erickson; Jeremy Patton; Laura Jane Hyte-Richins; Benjamin Z Rollins; Adam J Gordon Journal: Am J Drug Alcohol Abuse Date: 2020-12-10 Impact factor: 3.829
Authors: Emily C Williams; Madeline C Frost; Anna D Rubinsky; Joseph E Glass; Chelle L Wheat; Amy T Edmonds; Jessica A Chen; Theresa E Matson; Olivia V Fletcher; Keren Lehavot; John R Blosnich Journal: J Stud Alcohol Drugs Date: 2021-01 Impact factor: 2.582
Authors: Emily C Williams; Jessica A Chen; Madeline C Frost; Anna D Rubinsky; Amy T Edmonds; Joseph E Glass; Keren Lehavot; Theresa E Matson; Chelle L Wheat; Scott Coggeshall; John R Blosnich Journal: J Subst Abuse Treat Date: 2021-07-08